<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1538973079464292&amp;ev=PageView&amp;noscript=1">

Science and Research posts

Tafenoquine and Atovaquone Combo Shows Promise in Babesiosis Treatment
January 5, 2024
Learn about a breakthrough in the treatment of babesiosis using a combination of tafenoquine and atovaquone. This innovative approach shows potential for complete cure and immune protection, according to recent research. The current treatments for babesiosis can come with severe side effects, the ri...
What is Rapid or Point-Of-Care Testing for Lyme Disease?
October 18, 2023
By Jane M. Caldwell, Ph.D. – Executive Director, Medavera Inc., Springfield, MO and Elizabeth Lee-Lewandrowski, Ph.D., MPH - Assistant Professor, Harvard Medical School, Department of Pathology, Massachusetts General Hospital, Boston
American Society for Microbiology Publishes Minireview, Research Funded by GLA
May 14, 2022
American Society for Microbiology (ASM) has over 30,000 members, including researchers, educators, and health professionals. ASM is one of the largest life science societies in the world. The minireview covers "Borreliella burgdorferi Antimicrobial-Tolerant Persistence in Lyme Disease and Posttreatm...
Lyme Disease and Bell’s Palsy: New Considerations for Differential Diagnosis
March 28, 2022
Promising New Lyme Disease Antibiotic May Spare Microbiome
October 6, 2021
An exciting new finding by. Dr. Kim Lewis of Northeastern University gives hope that Lyme disease can be potentially treated without harming the microbiome Why is antibiotic treatment for Lyme disease often problematic? A significant side effect of treating Lyme disease is the disruption of the gut ...
Lyme Disease and Mental Disorders: It’s Not All in Your Head
July 29, 2021
A recent study in Denmark funded by Global Lyme Alliance analyzes patient data associated with Lyme disease and the impact it has on mental health Mental disorders are among the most poorly understood symptoms of Lyme disease. Early on, it was recognized that Lyme disease in late stages includes neu...
Meet the Researcher: Michael Eriksen Benros, M.D., Ph.D.
July 25, 2021
Michael Eriksen Benros, M.D., Ph.D. is professor and Head of Research at Mental Health Centre Copenhagen, Copenhagen University Hospital, Denmark. He received a two year grant from GLA for his study: Nationwide Cohort Studies Examining Psychiatric Disorders and Suicidal Behavior after Lyme disease.
Meet the Researcher: Shannon Delaney, M.D.
July 8, 2021
Shannon Delaney, M.D., is Director of Child and Adolescent Evaluation at the Lyme & Tick-borne Diseases Research Center, and Assistant Professor, Columbia University Vagelos College of Physicians and Surgeons. She is an expert in child and adult neuropsychiatry and infection-triggered neuropsych...
Borrelia miyamotoi: Hiding in Plain Sight?
May 22, 2021
GLA's Director of Research and Science, Dr. Mayla Hsu, discusses findings by Dr. Shannon Delaney, who suggests that Borrelia miyamotoi is an infectious trigger for chronic illness, closely resembling Lyme disease. What do we know about chronic illness following a Lyme disease diagnosis? We know that...
Meet the Researcher - George Aranjuez Ph.D.
March 29, 2021
George Aranjuez, Ph.D. is faculty research associate at University of Central Florida. His postdoctoral research was supported by a Deborah and Mark Blackman-GLA fellowship award. His most recent peer-reviewed articles, about the replication of Borrelia burgdorferi, appear here and here. Why did you...
Dendritic Cells: A Possible Pathway to Lyme Autoimmunity?
February 16, 2021
In the Covid-19 pandemic era, survival and recovery are on our minds. It’s become recognized that some patients recover quickly from Covid-19, but others may take months or possibly longer to feel better. Sound familiar? The Lyme disease community has a long experience with lingering, debilitating s...
Meet the Researcher: Maria Gutierrez-Hoffmann, Ph.D.
February 16, 2021
Maria Gutierrez-Hoffmann, Ph.D. is a scientist at the Food and Drug Administration in the Office of Pharmaceutical Manufacturing Assessment. As a postdoctoral fellow, her Lyme disease research was supported by GLA. Her most recent peer-reviewed publication is Borrelia burgdorferi-Induced Changes in ...
Lyme Disease Incidence: Even Greater Than Thought
February 5, 2021
POV by Timothy J. Sellati, Ph.D., Chief Scientific Officer, GLA How many people get Lyme disease every year? Precisely determining an annual incidence has been a challenge. Based upon a surveillance rather than a clinical definition, there is an ongoing discrepancy between Lyme disease cases reporte...
Meet the Researcher: Lise Nigrovic, M.D., M.P.H.
January 6, 2021
Meet the Researcher is a blog series to introduce GLA-funded Lyme disease researchers. Lise Nigrovic, M.D., M.P.H. is Associate Professor of Pediatrics and Emergency Medicine at Boston Children’s Hospital and Harvard Medical School in Boston, Massachusetts, USA.
An Innovative Approach To Understanding Pediatric Lyme Disease
December 28, 2020
by Mayla Hsu, Ph.D., Director of Research and Science, GLA
How Our Body ‘Sees’ Spirochetes Has Implications for Lyme Disease Severity and Novel Treatments
December 20, 2020
by Timothy J. Sellati, Ph.D., Chief Scientific Officer, GLA
The Similarities Between Post-COVID-19 and Lyme Disease
November 17, 2020
Tens of thousands of people in the U.S. have lingering illness following COVID-19, known as post-Covid “long haulers.” Why do some people recover relatively quickly from Lyme disease and Covid-19, and a significant number do not? by Mayla Hsu, Ph.D., Director of Research and Science, GLA
When Interpretation of Results Misses the Bull’s-eye
November 14, 2020
by Timothy J. Sellati, Ph.D., Chief Scientific Officer, GLA
Lyme Arthritis and Inflammation: Shut It Off!
September 23, 2020
A summary of 3 Lyme arthritis studies and how our immune system can fail to shut off when there’s an infection. by Mayla Hsu, Ph.D., Director of Research and Science, GLA
The need for an alternative to current antibody-based Lyme disease diagnostic tests
August 25, 2020
by Timothy J. Sellati, Ph.D., Chief Scientific Officer, Global Lyme Alliance